To enumerate people experiencing homelessness in the U.S., the federal Department of Housing and Urban Development (HUD) mandates its designated local jurisdictions regularly conduct a crude census of this population. This Point-in-Time (PIT) body count, typically conducted on a January night by volunteers with flashlights and clipboards, is often followed by interviews with a separate convenience sample. Here, we propose employing a network-based (peer-referral) respondent-driven sampling (RDS) method to generate a representative sample of unsheltered people, accompanied by a novel method to generate a statistical estimate of the number of unsheltered people in the jurisdiction. First, we develop a power analysis for the sample size of our RDS survey to count unsheltered people experiencing homelessness. Then, we conducted three large-scale population-representative samples in King County, WA (Seattle metro) in 2022, 2023, and 2024. We describe the data collection and the application of our new method, comparing the 2020 PIT count (the last visual PIT count performed in King County) to the new method 2022 and 2024 PIT counts. We conclude with a discussion and future directions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/aje/kwae342 | DOI Listing |
BMC Public Health
January 2025
Family and Community Medicine Department, College of Medicine, King Khalid University, Abha, Saudi Arabia.
Background: University students are more likely to experience mental disorders. This study aimed to assess the prevalence of depression, anxiety, and stress among health and non-health university students at King Khalid University students, Abha, Kingdom of Saudi Arabia.
Methods: An anonymous validated short form of Arabic questionnaire of the depression, anxiety, and stress scale (DASS-21) survey was distributed online on social media platforms and through face-to-face interview for 1700 students from March 1st to May 31st 2024.
NPJ Digit Med
January 2025
Department of Computer Science and Technology & Institute for Artificial Intelligence & BNRist, Tsinghua University, Beijing, China.
Rare diseases, affecting ~350 million people worldwide, pose significant challenges in clinical diagnosis due to the lack of experienced physicians and the complexity of differentiating between numerous rare diseases. To address these challenges, we introduce PhenoBrain, a fully automated artificial intelligence pipeline. PhenoBrain utilizes a BERT-based natural language processing model to extract phenotypes from clinical texts in EHRs and employs five new diagnostic models for differential diagnoses of rare diseases.
View Article and Find Full Text PDFTransl Psychiatry
January 2025
Center for Behavioral Sciences and Mental Health, Istituto Superiore di Sanità, Rome, Italy.
Predicting disease trajectories in patients with major depressive disorder (MDD) can allow designing personalized therapeutic strategies. In this study, we aimed to show that measuring patients' plasticity - that is the susceptibility to modify the mental state - identifies at baseline who will recover, anticipating the time to transition to wellbeing. We conducted a secondary analysis in two randomized clinical trials, STAR*D and CO-MED.
View Article and Find Full Text PDFJ Subst Use Addict Treat
January 2025
Department of Medicine, Oregon Health & Sciences University, Portland, OR, United States of America.
Introduction: People who use drugs (PWUD) are at risk of HIV infection, but the frequency and distribution of transmission-associated behaviors within rural communities is not well understood. Further, while interventions designed to more explicitly affirm individuals' sexual orientation and behaviors may be more effective, descriptions of behavior variability by orientation are lacking. We sought to describe how disease transmission behaviors and overdose risk vary by sexual orientation and activity among rural PWUD.
View Article and Find Full Text PDFNephron
January 2025
Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is a prevalent hereditary kidney disease and the fourth most common cause of kidney failure. Patients may be aware of their condition from an early age or discover it unexpectedly, with varying levels of familial knowledge about the disease. This chronic condition presents significant challenges for healthcare professionals.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!